Product Images Donepezil Hydrochloride

This appears to be a report of a clinical trial investigating the effects of a treatment on patients' cognitive function. The text presents data on the change in a measure called ADAS-cog, with percentages of patients achieving specific changes from baseline scores. Additionally, there is a graph depicting the cumulative percentage of patients who completed 24 weeks of treatment with specific changes from baseline ADAS-cog scores. The study had different treatment groups with doses of 5mg/day and 10mg/day, as well as a placebo group, and the percentages of randomized patients who completed the study are reported.*

The text appears to be a table with headers about the "percentage of patients" and their progress in a study. The first column seems to indicate the different categories where patients were grouped, possibly by severity or condition. The remaining columns contain text which indicates different possible outcomes, including improved, worsened and unchanged. There is also a reference to a frequency distribution of scores for a CIBIC test on week 24. It is unclear what the study is about or what the abbreviations stand for.*

The text describes a study that measures the effectiveness of a treatment on patients with ADAS-cog. The study involves three treatment groups: placebo, 5mg/day, and 10mg/day. The results show a change in ADAS-cog ranging from -5 to +7. The cumulative percentage of patients is shown in a graph, and the completion rates for each group are provided.*

The text contains a figure and a heading indicating the Cumulative Percentage of Patients completing 6 months of double-blind treatment with particular changes. The figure suggests that there is a change from the baseline, but the details are not available due to the not being able to read the text.*

This is a description of a medication called Donepezil. The details include information on its strength, packaging, manufacturing, and pharmacy services. The medication package is not child-resistant and the lot number is provided. There is confirmation that it has been checked by an examiner but the remaining text is not readable.*